Matches in SemOpenAlex for { <https://semopenalex.org/work/W4297317963> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W4297317963 abstract "<h3>Purpose</h3> Autoimmune myopathies are an heterogeneous group of diseases, among which polymyositis and dermatomyositis are probably the best known. Autoimmune myositis can overlap with other autoimmune rheumatic diseases, particularly it is a rare but recognized complication of systemic lupus erythematosus (SLE). Here we report a case of SLE-related myositis, successfully treated with combined immunosuppressive therapy with rituximab and immunoglobulin infusion and then relapsed due to rapid decalage of immunosuppressive therapy with mycophenolate mofetil. <h3>Methods</h3> A 28-year-old woman was affected from 2016 by SLE with haematological, articular and renal involvement treated with immunosuppressive therapy with good clinical response. After five years of disease remission, patient presented to the emergency department for a rapid onset of a clinical scenario with fever, alopecia, articular and muscular pain. The pharmacologic treatment was mycophenolate mofetil 500 mg/day (at this dose for about a year, after decalage by 2 gr/day), hydroxychloroquine 200 mg/day, belimumab 200 mg/week, prednisone 5 mg/day. On physical examination, she presented severe asthenia, pain on muscle palpation and loss of muscle tone with slight edema in the lower limbs. No signs of arthritis or active ulcers. Laboratory examinations revealed proteinuria > 2g/ 24h, severe increase of transaminases, phosphocreatine kinase, ANA positivity (titre1/2560) with high titres of anti-dsDNA and complementary consumption (both C3 and C4). Clinical and laboratoristic examinations raised the suspicion of SLE reactivation complicated by myositis. We performed a kidney biopsy with histological examimation suggestive for class IV lupus nephritis and an electromyography with a pattern of myositis. So we decided, according to disease involvement, to begin treatment with Rituximab (four administrations, 375 mg/m2) and gradual reintroduction of full-dose mycophenolate mofetil therapy (2 g/day). <h3>Results</h3> Disease activity was high so immunosuppressive therapy with high-dose corticosteroids, Rituximab and mycophenolate mofetil was started with subsequent good clinical response. One month after the infusion of Rituximab, muscle enzymes were yet elevated thus we added therapy with endovenous immunoglobulin with discrete clinical and laboratory improvement. <h3>Conclusions</h3> Pharmacological treatment with rituximab and endovenous immunoglobulin can be considered as a good and safe therapeutic option for clinical management of SLE-related myositis. This clinical case underlines the importance of maintaining immunosuppressive treatment for a long period, and to decrease dose very slightly, when disease is in long remission." @default.
- W4297317963 created "2022-09-28" @default.
- W4297317963 creator A5026754051 @default.
- W4297317963 creator A5028698640 @default.
- W4297317963 creator A5036749346 @default.
- W4297317963 creator A5053171667 @default.
- W4297317963 creator A5070816758 @default.
- W4297317963 creator A5073016362 @default.
- W4297317963 date "2022-09-27" @default.
- W4297317963 modified "2023-09-25" @default.
- W4297317963 title "PO.6.123 A rapid decalage of immunosuppressive therapy in a young woman with systemic lupus erythematosus" @default.
- W4297317963 doi "https://doi.org/10.1136/lupus-2022-elm2022.144" @default.
- W4297317963 hasPublicationYear "2022" @default.
- W4297317963 type Work @default.
- W4297317963 citedByCount "1" @default.
- W4297317963 countsByYear W42973179632023 @default.
- W4297317963 crossrefType "proceedings-article" @default.
- W4297317963 hasAuthorship W4297317963A5026754051 @default.
- W4297317963 hasAuthorship W4297317963A5028698640 @default.
- W4297317963 hasAuthorship W4297317963A5036749346 @default.
- W4297317963 hasAuthorship W4297317963A5053171667 @default.
- W4297317963 hasAuthorship W4297317963A5070816758 @default.
- W4297317963 hasAuthorship W4297317963A5073016362 @default.
- W4297317963 hasBestOaLocation W42973179631 @default.
- W4297317963 hasConcept C126322002 @default.
- W4297317963 hasConcept C16005928 @default.
- W4297317963 hasConcept C203014093 @default.
- W4297317963 hasConcept C2776694085 @default.
- W4297317963 hasConcept C2776755627 @default.
- W4297317963 hasConcept C2776912625 @default.
- W4297317963 hasConcept C2778720950 @default.
- W4297317963 hasConcept C2778751314 @default.
- W4297317963 hasConcept C2779123688 @default.
- W4297317963 hasConcept C2779134260 @default.
- W4297317963 hasConcept C2779338263 @default.
- W4297317963 hasConcept C2779387793 @default.
- W4297317963 hasConcept C2779912601 @default.
- W4297317963 hasConcept C2780653079 @default.
- W4297317963 hasConcept C2781232998 @default.
- W4297317963 hasConcept C3008058167 @default.
- W4297317963 hasConcept C524204448 @default.
- W4297317963 hasConcept C71924100 @default.
- W4297317963 hasConcept C90924648 @default.
- W4297317963 hasConceptScore W4297317963C126322002 @default.
- W4297317963 hasConceptScore W4297317963C16005928 @default.
- W4297317963 hasConceptScore W4297317963C203014093 @default.
- W4297317963 hasConceptScore W4297317963C2776694085 @default.
- W4297317963 hasConceptScore W4297317963C2776755627 @default.
- W4297317963 hasConceptScore W4297317963C2776912625 @default.
- W4297317963 hasConceptScore W4297317963C2778720950 @default.
- W4297317963 hasConceptScore W4297317963C2778751314 @default.
- W4297317963 hasConceptScore W4297317963C2779123688 @default.
- W4297317963 hasConceptScore W4297317963C2779134260 @default.
- W4297317963 hasConceptScore W4297317963C2779338263 @default.
- W4297317963 hasConceptScore W4297317963C2779387793 @default.
- W4297317963 hasConceptScore W4297317963C2779912601 @default.
- W4297317963 hasConceptScore W4297317963C2780653079 @default.
- W4297317963 hasConceptScore W4297317963C2781232998 @default.
- W4297317963 hasConceptScore W4297317963C3008058167 @default.
- W4297317963 hasConceptScore W4297317963C524204448 @default.
- W4297317963 hasConceptScore W4297317963C71924100 @default.
- W4297317963 hasConceptScore W4297317963C90924648 @default.
- W4297317963 hasLocation W42973179631 @default.
- W4297317963 hasLocation W42973179632 @default.
- W4297317963 hasOpenAccess W4297317963 @default.
- W4297317963 hasPrimaryLocation W42973179631 @default.
- W4297317963 hasRelatedWork W1492391514 @default.
- W4297317963 hasRelatedWork W18358423 @default.
- W4297317963 hasRelatedWork W1990906958 @default.
- W4297317963 hasRelatedWork W2050260467 @default.
- W4297317963 hasRelatedWork W2133006674 @default.
- W4297317963 hasRelatedWork W2344307926 @default.
- W4297317963 hasRelatedWork W2788700111 @default.
- W4297317963 hasRelatedWork W4213199341 @default.
- W4297317963 hasRelatedWork W4214494386 @default.
- W4297317963 hasRelatedWork W70309806 @default.
- W4297317963 isParatext "false" @default.
- W4297317963 isRetracted "false" @default.
- W4297317963 workType "article" @default.